Abstract
About 1-in-20 children and adolescents have attention deficit hyperactivity disorder (ADHD). Parental training and education, and psychological treatment for patients, are the usual first-line treatments for moderate ADHD. NICE recommends drugs for severe ADHD, as well as for children with moderate ADHD who refused non-drug treatment, or whose symptoms and impairment did not respond adequately to training, education and psychological treatment. The drug choice needs to be individualised, form part of a comprehensive treatment plan and carers (including school staff) need to remain alert for adverse events. This article briefly introduces the place of, and some issues surrounding, stimulants for ADHD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
